Additionally, mitigated leaky gut syndrome suggests that BPC 157 is a stabilizer of cellular junctions by increasing tight junction protein ZO-1 expression and transepithelial resistance (Sucic et al., 2019) occurred in both ischemic and reperfusion conditions in various tissues (i.e., colon, duodenum, cecum, liver, and veins) and plasma, in vessel occlusion studies in particular (Vukojevic et al., 2018
Sources Sikiric P, Hahm KB, Blagaic AB, et al
A beta cell ATGL-lipolysis/adipose tissue axis controls energy homeostasis and body weight via insulin secretion in mice
Novo Nordisk filed for FDA approval on December 18, 2025
Mechanisms of action and therapeutic application of glucagon-like peptide-1